Central Retinal Vein Occlusion: Clinical Trials

1 trial for Central Retinal Vein Occlusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Central Retinal Vein Occlusion: new trials by email Literature Review of Central Retinal Vein Occlusion trials Research Report on Central Retinal Vein Occlusion

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion
Ozurdex, Ranibizumab, Combination Ozurdex with Ranibizumab PRN - Macular Edema, Central Retinal Vein Occlusion
Phase 4UnknownValley Retina Institute452013-05-012015-12-14

Narrower conditions

Macular Edema (1)  ·  Retinal Vein Occlusion (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Eye Diseases (1)  ·  Macular Degeneration (1)  ·  Retinal Degeneration (1)  ·  Retinal Diseases (1)  ·  Thrombosis (1)  ·  Vascular Diseases (1)  ·  Venous Thrombosis (1)

Interventions

Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Ranibizumab (1)

Sponsors

Valley Retina Institute (1)

Countries

United States (1)